| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Elvevåg B | |
| Goldberg TE | |||
| P433 | issue | 1 | |
| P921 | main subject | cognitive dysfunction | Q57859955 |
| schizophrenia | Q41112 | ||
| P304 | page(s) | 1-21 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Critical reviews in neurobiology | Q27710330 |
| P1476 | title | Cognitive impairment in schizophrenia is the core of the disorder | |
| P478 | volume | 14 |
| Q30452392 | "To see or not to see: that is the question." The "Protection-Against-Schizophrenia" (PaSZ) model: evidence from congenital blindness and visuo-cognitive aberrations |
| Q30478713 | 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia |
| Q58576341 | A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology |
| Q37428330 | A broken filter: prefrontal functional connectivity abnormalities in schizophrenia during working memory interference |
| Q91829218 | A comparison between the Mini-Mental State Examination and the Montreal Cognitive Assessment Test in schizophrenia |
| Q30579319 | A computational language approach to modeling prose recall in schizophrenia |
| Q42665096 | A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice |
| Q37101302 | A genome screen for quantitative trait loci influencing schizophrenia and neurocognitive phenotypes |
| Q41724432 | A self administered executive functions ecological questionnaire (the behavior rating inventory of executive function - adult version) shows impaired scores in a sample of patients with schizophrenia |
| Q48137280 | A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia |
| Q33668339 | A virtual reality task based on animal research - spatial learning and memory in patients after the first episode of schizophrenia |
| Q90252559 | Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task |
| Q30488298 | Activation of dopamine D1 receptors blocks phencyclidine-induced neurotoxicity by enhancing N-methyl-D-aspartate receptor-mediated synaptic strength |
| Q51972909 | Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats. |
| Q38846609 | Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model |
| Q37247909 | Akting up in the GABA hypothesis of schizophrenia: Akt1 deficiency modulates GABAergic functions and hippocampus-dependent functions |
| Q30494823 | Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia |
| Q34384480 | Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia |
| Q36103816 | Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia |
| Q26827100 | Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies |
| Q34462143 | Altered expression of regulators of the cortical chloride transporters NKCC1 and KCC2 in schizophrenia |
| Q30409382 | Altered object-in-place recognition memory, prepulse inhibition, and locomotor activity in the offspring of rats exposed to a viral mimetic during pregnancy |
| Q37418303 | Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects |
| Q34356542 | Altered social behaviours in neurexin 1α knockout mice resemble core symptoms in neurodevelopmental disorders. |
| Q52657062 | An Event Related Potentials Study of Semantic Coherence Effect during Episodic Encoding in Schizophrenia Patients. |
| Q35579197 | An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia. |
| Q33772253 | An automated method to analyze language use in patients with schizophrenia and their first-degree relatives |
| Q35810076 | Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia |
| Q37127670 | Anterior Cingulate Cortico-Hippocampal Dysconnectivity in Unaffected Relatives of Schizophrenia Patients: A Stochastic Dynamic Causal Modeling Study |
| Q36241105 | Anterior cingulate cortex-related connectivity in first-episode schizophrenia: a spectral dynamic causal modeling study with functional magnetic resonance imaging |
| Q36940014 | Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial |
| Q35990236 | Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine. |
| Q60046495 | Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia |
| Q33398673 | Apathy is associated with executive functioning in first episode psychosis |
| Q35103789 | Assessment of cognitive function in the heterozygous reeler mouse |
| Q92245011 | Association between developmental milestones and age of schizophrenia onset: Results from the Northern Finland Birth Cohort 1966 |
| Q30371601 | Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model. |
| Q36324947 | Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set. |
| Q36770093 | Birth weight and neurocognition in schizophrenia spectrum disorders |
| Q36320593 | Brain activation patterns during visual episodic memory processing among first-degree relatives of schizophrenia subjects |
| Q30862013 | Brainnetome of schizophrenia: focus on impaired cognitive function |
| Q38218667 | Bridging disparate symptoms of schizophrenia: a triple network dysfunction theory |
| Q30497212 | Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. |
| Q37346469 | Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia |
| Q37710469 | Cerebello-thalamo-cortical networks predict positive symptom progression in individuals at ultra-high risk for psychosis |
| Q26747552 | Chandelier Cells in Functional and Dysfunctional Neural Circuits |
| Q50421623 | Chronic MK-801 Application in Adolescence and Early Adulthood: A Spatial Working Memory Deficit in Adult Long-Evans Rats But No Changes in the Hippocampal NMDA Receptor Subunits |
| Q38392954 | Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset |
| Q37081349 | Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration |
| Q28730147 | Cigarette smoking and cognitive function in Chinese male schizophrenia: a case-control study |
| Q33565101 | Clinical and biochemical study of d-serine metabolism among schizophrenia patients |
| Q40494872 | Clozapine Reverses Phencyclidine-Induced Desynchronization of Prefrontal Cortex through a 5-HT(1A) Receptor-Dependent Mechanism. |
| Q30396291 | Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking |
| Q35129327 | Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy. |
| Q52014550 | Cognitive predictors of skill acquisition on social problem solving in patients with schizophrenia. |
| Q46017020 | Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats. |
| Q33851041 | Common and specific cognitive deficits in schizophrenia: relationships to function |
| Q36966300 | Comparing experiential acceptance and cognitive reappraisal as predictors of functional outcome in individuals with serious mental illness |
| Q35898729 | Comparing retrospective reports to real-time/real-place mobile assessments in individuals with schizophrenia and a nonclinical comparison group |
| Q30407820 | Comprehensive behavioral analysis of voltage-gated calcium channel beta-anchoring and -regulatory protein knockout mice |
| Q35654995 | Comprehensive family therapy: an effective approach for cognitive rehabilitation in schizophrenia |
| Q24678573 | Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia |
| Q47619705 | Consumer satisfaction with antipsychotic medication-monitoring appointments: the role of consumer-prescriber communication patterns |
| Q30455334 | Contribution of NMDA receptor hypofunction in prefrontal and cortical excitatory neurons to schizophrenia-like phenotypes |
| Q37139004 | Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia |
| Q37973314 | Cortical basket cell dysfunction in schizophrenia |
| Q33847022 | Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia |
| Q34693662 | Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex |
| Q35750348 | Deficits in cue detection and intention retrieval underlie prospective memory impairment in schizophrenia |
| Q26991935 | Dendritic spine pathology in schizophrenia |
| Q55709295 | Deterioration in Global Organization of Structural Brain Networks in Schizophrenia: A Diffusion MRI Tractography Study. |
| Q38101720 | Development and specification of GABAergic cortical interneurons |
| Q64056411 | Differential of Frequency and Duration Mismatch Negativity and Theta Power Deficits in First-Episode and Chronic Schizophrenia |
| Q48794817 | Directed forgetting in schizophrenia: prefrontal memory and inhibition deficits |
| Q37075798 | Disruption of anterior insula modulation of large-scale brain networks in schizophrenia |
| Q33976994 | Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia |
| Q33637725 | Do people with schizophrenia have differential impairment in episodic memory and/or working memory relative to other cognitive abilities? |
| Q35037753 | Does degree of gyrification underlie the phenotypic and genetic associations between cortical surface area and cognitive ability? |
| Q37075965 | Does self-perceived mood predict more variance in cognitive performance than clinician-rated symptoms in schizophrenia? |
| Q36618769 | Dopamine D1 receptor activation improves PCP-induced performance disruption in the 5C-CPT by reducing inappropriate responding |
| Q28273285 | Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors |
| Q52804720 | Dunce Phosphodiesterase Acts as a Checkpoint for Drosophila Long-Term Memory in a Pair of Serotonergic Neurons. |
| Q37357632 | Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression |
| Q30573050 | Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning |
| Q28509414 | Dysregulation of presynaptic calcium and synaptic plasticity in a mouse model of 22q11 deletion syndrome |
| Q30453712 | ENU-mutagenesis mice with a non-synonymous mutation in Grin1 exhibit abnormal anxiety-like behaviors, impaired fear memory, and decreased acoustic startle response |
| Q36219472 | Early cognitive experience prevents adult deficits in a neurodevelopmental schizophrenia model |
| Q24654374 | Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys |
| Q43104595 | Effects of Add-on Ramelteon on Cognitive Impairment in Patients with Schizophrenia: An Open-label Pilot Trial. |
| Q64078147 | Effects of Amisulpride Adjunctive Therapy on Working Memory and Brain Metabolism in the Frontal Cortex of Patients with Schizophrenia: A Preliminary Positron Emission Tomography/Computerized Tomography Investigation |
| Q38965146 | Effects of D- and L-govadine on the disruption of touchscreen object-location paired associates learning in rats by acute MK-801 treatment. |
| Q24795422 | Effects of acute tryptophan depletion on executive function in healthy male volunteers |
| Q33936354 | Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats |
| Q28533794 | Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. |
| Q38597098 | Effects of transcranial direct current stimulation on the auditory mismatch negativity response and working memory performance in schizophrenia: a pilot study |
| Q93067077 | Endophenotypes in Schizophrenia: Digging Deeper to Identify Genetic Mechanisms |
| Q92257591 | Epidemiological Aspects of Cognitive and Socio-Professional Integration in Schizophrenia |
| Q36837668 | Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans |
| Q38008577 | Evaluating the links between schizophrenia and sleep and circadian rhythm disruption |
| Q36105449 | Event-related brain potential correlates of prospective memory in symptomatically remitted male patients with schizophrenia |
| Q37480047 | Executive function, neural circuitry, and genetic mechanisms in schizophrenia |
| Q30997126 | Exome Sequence Data From Multigenerational Families Implicate AMPA Receptor Trafficking in Neurocognitive Impairment and Schizophrenia Risk |
| Q90727929 | Exploring the associations of herpes simplex virus infection and cognitive dysfunction in schizophrenia: Studies in India |
| Q33831045 | Expressions of neuregulin 1beta and ErbB4 in prefrontal cortex and hippocampus of a rat schizophrenia model induced by chronic MK-801 administration. |
| Q37088924 | Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia |
| Q34618344 | Frequency dependent alterations in regional homogeneity of baseline brain activity in schizophrenia |
| Q34438284 | Functional and anatomical connectivity abnormalities in cognitive division of anterior cingulate cortex in schizophrenia |
| Q90010443 | Functional connectome-wide associations of schizophrenia polygenic risk |
| Q35916950 | GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia |
| Q37707319 | GABA level, gamma oscillation, and working memory performance in schizophrenia |
| Q30479407 | GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders |
| Q41717521 | Gender differences measured by the MATRICS consensus cognitive battery in chronic schizophrenia patients |
| Q24612644 | Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia |
| Q35173644 | Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disorders |
| Q30506046 | Glutamatergic modulation of auditory information processing in the human brain |
| Q24795192 | Habitual prospective memory in schizophrenia |
| Q40258756 | High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls |
| Q36053292 | Hippocampal temporal-parietal junction interaction in the production of psychotic symptoms: a framework for understanding the schizophrenic syndrome |
| Q36960113 | Immature dentate gyrus: an endophenotype of neuropsychiatric disorders. |
| Q35234966 | Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. |
| Q37193521 | Impaired conscious and preserved unconscious inhibitory processing in recent onset schizophrenia |
| Q37411819 | Impaired hippocampal ripple-associated replay in a mouse model of schizophrenia |
| Q28756538 | Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia |
| Q45245234 | Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia |
| Q48292762 | In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain |
| Q42913350 | Infragranular gene expression disturbances in the prefrontal cortex in schizophrenia: signature of altered neural development? |
| Q48168253 | Inhibition of neuronal nitric oxide synthase prevents alterations in medial prefrontal cortex excitability induced by repeated cocaine administration |
| Q36677817 | Insight and subjective measures of quality of life in chronic schizophrenia |
| Q34247716 | Interneuron dysfunction in psychiatric disorders |
| Q21132531 | Intra- and inter-frequency brain network structure in health and schizophrenia |
| Q30418674 | Investigation of gene effects and epistatic interactions between Akt1 and neuregulin 1 in the regulation of behavioral phenotypes and social functions in genetic mouse models of schizophrenia |
| Q30417611 | Isolation rearing effects on probabilistic learning and cognitive flexibility in rats |
| Q50043443 | Ketamine alters lateral prefrontal oscillations in a rule-based working memory task. |
| Q47662227 | Ketamine-Induced Changes in the Signal and Noise of Rule Representation in Working Memory by Lateral Prefrontal Neurons. |
| Q92487994 | Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation |
| Q34664140 | LORETA current source density for duration mismatch negativity and neuropsychological assessment in early schizophrenia |
| Q89088687 | Linked 4-Way Multimodal Brain Differences in Schizophrenia in a Large Chinese Han Population |
| Q37628337 | Linking microcircuit dysfunction to cognitive impairment: effects of disinhibition associated with schizophrenia in a cortical working memory model |
| Q38207021 | Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system |
| Q36531343 | Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment |
| Q24656111 | Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications |
| Q36092603 | Mini Mental State Examination (MMSE) in First Episode of Psychosis |
| Q30439908 | Mismatch negativity latency and cognitive function in schizophrenia |
| Q39408715 | Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs). |
| Q34113362 | Modulation of prepulse inhibition and stereotypies in rodents: no evidence for antipsychotic-like properties of histamine H3-receptor inverse agonists |
| Q24648527 | Motor coordination deficits in mice lacking RGS9 |
| Q30432964 | Mouse models for studying genetic influences on factors determining smoking cessation success in humans |
| Q48134954 | NMDA antagonist ketamine reduces task selectivity in macaque dorsolateral prefrontal neurons and impairs performance of randomly interleaved prosaccades and antisaccades |
| Q39931392 | Network Profiles of the Dorsal Anterior Cingulate and Dorsal Prefrontal Cortex in Schizophrenia During Hippocampal-Based Associative Memory |
| Q88588695 | Neural Correlates of Auditory Verbal Hallucinations in Schizophrenia and the Therapeutic Response to Theta-Burst Transcranial Magnetic Stimulation |
| Q35624356 | Neuregulin 1 expression and electrophysiological abnormalities in the Neuregulin 1 transmembrane domain heterozygous mutant mouse |
| Q33606029 | Neurocognitive Decrements are Present in Intellectually Superior Schizophrenia |
| Q36740424 | Neurocognitive deficits and prefrontal cortical atrophy in patients with schizophrenia. |
| Q33762525 | Neurocognitive pattern analysis reveals classificatory hierarchy of attention deficits in schizophrenia |
| Q35768261 | Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation |
| Q34662630 | Neurogenic actions of atypical antipsychotic drugs and therapeutic implications |
| Q26824953 | Neuronal migration abnormalities and its possible implications for schizophrenia |
| Q55395083 | Neuropharmacological Potential and Delivery Prospects of Thymoquinone for Neurological Disorders. |
| Q33581386 | Neurophysiological Evidence of Compensatory Brain Mechanisms Underlying Attentional-Related Processes in Symptomatically Remitted Patients with Schizophrenia |
| Q37310190 | Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders |
| Q56992231 | Neuropsychological impairments predict the clinical course in schizophrenia |
| Q36957681 | Neuropsychological substrates and everyday functioning implications of prospective memory impairment in schizophrenia. |
| Q30462575 | Nicotine, Auditory Sensory Memory, and sustained Attention in a Human Ketamine Model of Schizophrenia: Moderating Influence of a Hallucinatory Trait |
| Q47404190 | Nicotine-induced activation of caudate and anterior cingulate cortex in response to errors in schizophrenia |
| Q30499718 | Nogo Receptor 1 (RTN4R) as a candidate gene for schizophrenia: analysis using human and mouse genetic approaches |
| Q50331698 | Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex |
| Q35646296 | Oxytocin and social cognition in affective and psychotic disorders |
| Q41850803 | Patients with schizophrenia show aberrant patterns of basal ganglia activation: Evidence from ALE meta-analysis |
| Q30359319 | Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice. |
| Q58604374 | Pharmacological characterization of JWX-A0108 as a novel type I positive allosteric modulator of α7 nAChR that can reverse acoustic gating deficits in a mouse prepulse inhibition model |
| Q26774767 | Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia |
| Q34557613 | Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders |
| Q55380108 | Polygenic pleiotropy and potential causal relationships between educational attainment, neurobiological profile, and positive psychotic symptoms. |
| Q35747146 | Prediction of functional outcome in individuals at clinical high risk for psychosis |
| Q37699372 | Prefrontal brain network connectivity indicates degree of both schizophrenia risk and cognitive dysfunction |
| Q38252882 | Prefrontal dopamine in associative learning and memory. |
| Q30409892 | Prenatal exposure to a viral mimetic alters behavioural flexibility in male, but not female, rats. |
| Q37013377 | Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system |
| Q35626908 | Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex |
| Q34404178 | Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study. |
| Q41910174 | Prospective memory impairments in schizophrenic patients |
| Q43115257 | Pyramidal neurons in rat prefrontal cortex projecting to ventral tegmental area and dorsal raphe nucleus express 5-HT2A receptors |
| Q35141174 | Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices |
| Q34486230 | Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial |
| Q33932087 | Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia |
| Q46981404 | Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness. |
| Q33833761 | Relationships between dorsolateral prefrontal cortex metabolic change and cognitive impairment in first-episode neuroleptic-naive schizophrenia patients. |
| Q35024121 | Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats |
| Q35404577 | Response inhibition and response monitoring in a saccadic double-step task in schizophrenia |
| Q41978023 | Robust sequential working memory recall in heterogeneous cognitive networks |
| Q45921170 | Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat. |
| Q38596474 | Role of presynaptic phosphoprotein synapsin II in schizophrenia |
| Q36625535 | Rorschach measures of cognition relate to everyday and social functioning in schizophrenia. |
| Q34564181 | Schizophrenia and potentially preventable hospitalizations in the United States: a retrospective cross-sectional study |
| Q36551460 | Schizophrenia genetic variants are not associated with intelligence |
| Q90427341 | Schizophrenia-related dysbindin-1 gene is required for innate immune response and homeostasis in the developing subventricular zone |
| Q36517227 | Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? |
| Q36478249 | Schizophrenia: an integrative approach to modelling a complex disorder. |
| Q35810087 | Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction |
| Q43166015 | Serotonin modulates fast-spiking interneuron and synchronous activity in the rat prefrontal cortex through 5-HT1A and 5-HT2A receptors. |
| Q36778507 | Serotonin modulation of cortical neurons and networks |
| Q24597744 | Should cognitive deficit be a diagnostic criterion for schizophrenia? |
| Q35554778 | Sleep correlates of cognition in early course psychotic disorders |
| Q36554531 | Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study |
| Q94551179 | Subjective cognitive complaints and its relation to objective cognitive performance, clinical profile, clinical insight, and social functioning in patients of schizophrenia: A cross-sectional study |
| Q33724829 | Sustained attention and planning deficits but intact attentional set-shifting in neuroleptic-naïve first-episode schizophrenia patients |
| Q37444933 | Synaptic Actin Dysregulation, a Convergent Mechanism of Mental Disorders? |
| Q33842202 | Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location |
| Q34317550 | Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction |
| Q21134998 | Temporal information processing in short- and long-term memory of patients with schizophrenia |
| Q30468033 | The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders |
| Q91789149 | The Efficacy, Feasibility And Acceptability Of A Remotely Accessible Use Of CIRCuiTS, A Computerized Cognitive Remediation Therapy Program For Schizophrenia: A Pilot Study |
| Q37407425 | The NCAN gene: schizophrenia susceptibility and cognitive dysfunction |
| Q35987875 | The Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric Properties |
| Q39034895 | The Processing-Speed Impairment in Psychosis Is More Than Just Accelerated Aging |
| Q46072268 | The amphetamine sensitization model of schizophrenia: relevance beyond psychotic symptoms? |
| Q35237288 | The assessment of neuropsychological functioning in schizophrenia |
| Q34625777 | The chandelier neuron in schizophrenia |
| Q30457705 | The developing utility of zebrafish models for cognitive enhancers research |
| Q45254522 | The effects of eticlopride on Morris water task performance in male and female rats neonatally treated with quinpirole |
| Q35740788 | The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time task |
| Q36683838 | The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis |
| Q28568053 | The involvement of Type II Neuregulin-1 in rat visuospatial learning and memory |
| Q38444895 | The negative priming paradigm: An update and implications for selective attention |
| Q55085761 | The neuropsychology of emerging psychosis and the role of working memory in episodic memory encoding. |
| Q37307709 | The role of general intelligence as an intermediate phenotype for neuropsychiatric disorders |
| Q37284456 | The role of prefrontal dopamine D1 receptors in the neural mechanisms of associative learning. |
| Q35154852 | The selective impairment of resting-state functional connectivity of the lateral subregion of the frontal pole in schizophrenia. |
| Q38635337 | Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective |
| Q24629337 | Toxoplasma gondii and schizophrenia |
| Q44843752 | Transient disruption of attentional performance following escalating amphetamine administration in rats |
| Q58758781 | Uncoupling DISC1 × D2R Protein-Protein Interactions Facilitates Latent Inhibition in Disc1-L100P Animal Model of Schizophrenia and Enhances Synaptic Plasticity via D2 Receptors |
| Q50535284 | Unique Molecular Regulation of Higher-Order Prefrontal Cortical Circuits: Insights into the Neurobiology of Schizophrenia. |
| Q27009585 | Update on the development of lurasidone as a treatment for patients with acute schizophrenia |
| Q35485492 | Variable global dysconnectivity and individual differences in schizophrenia |
| Q45078539 | Why do schizophrenic patients smoke? |
| Q30465290 | Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice. |
Search more.